High- and Low-dose radiotherapy

RADIATION2 trials

Sponsors

Jiangxi Provincial Cancer Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Conditions

Immune ResponseMetastatic CancerRadiotherapy-Induced Immune PrimingRefractory Colorectal Cancer

Phase 2

Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study

Not yet recruitingNCT07467590

Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityImmune Response, Radiotherapy-Induced Immune Priming, Refractory Colorectal Cancer

Start: 2026-04-01End: 2029-04-01Target: 33Updated: 2026-03-12

Unknown Phase

High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor

Jiangxi Provincial Cancer HospitalMetastatic Cancer

Start: 2023-03-01End: 2025-02-20Target: 33Updated: 2023-03-07